Deregulation of the NF-κB pathway and its aberrant stimulation has been implicated as a primordial factor in driving tumorigenesis and cancer aggressiveness that correlate with poor survival in various malignancies, including prostate cancer [8,9]. The gene discussed is NFKB1; the disease is prostate cancer.